Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 55 3 10 14 60
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 1 17 1 5 10 52
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 10 0 8 15 52
Drug Advertising and Health Habit 0 0 0 70 1 5 6 421
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 2 8 12 70
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 27 0 5 11 63
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 3 17 22 125
Is Zero a Special Price? Evidence from Child Healthcare 1 3 3 36 2 14 18 113
Long-term Care in Japan 0 1 2 21 4 14 20 48
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 0 5 6 44
Robots and Labor in Nursing Homes 0 1 1 39 5 14 23 41
Robots and Labor in the Service Sector: Evidence from Nursing Homes 0 0 0 60 2 5 14 133
Total Working Papers 1 5 7 426 23 110 171 1,222


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 0 3 74 1 9 20 263
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 1 11 17 41
Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care 1 1 4 7 1 7 14 102
Cartel sustainability in retail markets: Evidence from a health service sector 0 0 0 19 1 6 13 128
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 2 8 8 28
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 0 5 0 2 3 11
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 0 0 1 79 1 2 4 239
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 0 4 8 71
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 1 36 0 4 6 145
Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design 0 0 0 1 3 8 8 14
Experts' agency problems: evidence from the prescription drug market in Japan 0 0 0 34 2 8 10 142
False alarm? Estimating the marginal value of health signals 0 0 0 6 1 10 20 75
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 0 3 5 123
Is Zero a Special Price? Evidence from Child Health Care 0 1 2 13 3 10 21 55
Patient cost sharing and medical expenditures for the Elderly 0 1 2 25 4 11 15 134
Physician Agency and Adoption of Generic Pharmaceuticals 0 2 4 64 0 9 15 293
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 0 3 2 5 7 36
The Effect of Prescription Drug Advertising on Doctor Visits 1 1 2 82 2 10 16 333
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 1 12 2 14 21 56
The generic drug market in Japan: will it finally take off? 0 0 1 32 6 9 11 104
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 0 1 119 2 4 6 434
Total Journal Articles 2 6 22 656 34 154 248 2,827


Statistics updated 2026-03-04